San Diego-based mostly Viking Therapeutics marked by itself as a serious competitor within the weight loss drug market in February right after revealing promising details from the mid-phase demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection and in March the c